APA

De Marchi T., Liu N. Q., Stingl C., Timmermans M. A., Smid M., Look M. P., Tjoa M., Braakman R. B. H., Opdam M., Linn S. C., Sweep F. C. G. J., Span P. N., Kliffen M., Luider T. M., Foekens J. A., Martens J. W. M. & Umar A. (20161019). 4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer. : Molecular oncology.

Chicago

De Marchi Tommaso, Liu Ning Qing, Stingl Cristoph, Timmermans Mieke A, Smid Marcel, Look Maxime P, Tjoa Mila, Braakman Rene B H, Opdam Mark, Linn Sabine C, Sweep Fred C G J, Span Paul N, Kliffen Mike, Luider Theo M, Foekens John A, Martens John W M and Umar Arzu. 20161019. 4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer. : Molecular oncology.

Harvard

De Marchi T., Liu N. Q., Stingl C., Timmermans M. A., Smid M., Look M. P., Tjoa M., Braakman R. B. H., Opdam M., Linn S. C., Sweep F. C. G. J., Span P. N., Kliffen M., Luider T. M., Foekens J. A., Martens J. W. M. and Umar A. (20161019). 4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer. : Molecular oncology.

MLA

De Marchi Tommaso, Liu Ning Qing, Stingl Cristoph, Timmermans Mieke A, Smid Marcel, Look Maxime P, Tjoa Mila, Braakman Rene B H, Opdam Mark, Linn Sabine C, Sweep Fred C G J, Span Paul N, Kliffen Mike, Luider Theo M, Foekens John A, Martens John W M and Umar Arzu. 4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer. : Molecular oncology. 20161019.